Equities

USANA Health Sciences Inc

USANA Health Sciences Inc

Actions
Consumer Staples Food Producers
  • Price (USD)48.52
  • Today's Change0.245 / 0.51%
  • Shares traded31.57k
  • 1 Year change-22.80%
  • Beta0.9072
Data delayed at least 15 minutes, as of Mar 28 2024 19:07 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Company’s product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.

  • Revenue in USD (TTM)921.01m
  • Net income in USD63.79m
  • Incorporated1992
  • Employees1.80k
  • Location
    USANA Health Sciences Inc3838 W Parkway BlvdSALT LAKE CITY 84120-6336United StatesUSA
  • Phone+1 (801) 954-7100
  • Fax+1 (801) 956-9486
  • Websitehttps://www.usana.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tyra Biosciences Inc0.00-69.13m856.09m49.00--3.43-----1.62-1.620.004.750.00----0.00-28.10---29.36--------------0.00-------24.96------
Evolus Inc202.09m-61.69m859.24m273.00------4.25-1.08-1.083.55-0.35781.104.127.63740,238.10-33.62-40.92-45.33-59.7469.5465.43-30.52-80.462.10-3.471.21--35.98--17.10--182.77--
Nuvation Bio Inc0.00-75.80m869.61m51.00--1.44-----0.3463-0.34630.002.760.00----0.00-11.72-16.27-11.97-16.65------------0.00------27.25------
Enliven Therapeutics Inc0.00-71.58m870.11m46.00--3.13-----2.18-2.180.005.950.00----0.00-40.31-42.26-44.80-46.62------------0.00-------4,910.75------
Pliant Therapeutics Inc1.58m-161.34m876.48m158.00--1.84--554.73-2.75-2.750.02697.900.0037--1.5910,000.00-37.40-33.24-39.82-35.39-----10,211.14-360.29----0.0208---83.69---30.83---16.89--
CARGO Therapeutics Inc0.00-98.15m882.13m116.00--2.28-----2.37-2.370.009.84------0.00--------------------0.00-------139.67------
Cassava Sciences Inc0.00-97.22m882.66m29.00--6.27-----2.32-2.320.003.250.00----0.00-50.31-30.74-53.23-32.12------------0.00-------27.50------
Arcturus Therapeutics Holdings Inc166.80m-29.73m884.43m180.00--3.17--5.30-1.16-1.166.2310.380.3792--9.58926,661.10-6.76-19.66-8.86-24.90-----17.82-77.55----0.00---19.0360.31-417.95--14.44--
Dianthus Therapeutics Inc2.83m-43.56m898.01m53.00--2.69--317.77-10.77-10.770.442911.400.0173----53,320.75-26.72-41.40-28.86-44.70-----1,541.22-12,132.27----0.00------43.04---57.21--
ORIC Pharmaceuticals Inc0.00-100.70m907.22m100.00--3.30-----1.97-1.970.004.080.00----0.00-40.34-33.92-43.47-35.77------------0.00-------12.99--10.09--
USANA Health Sciences, Inc.921.01m63.79m928.74m1.80k14.641.8612.141.013.303.3047.6125.991.502.75--511,672.2010.3816.2313.2021.7580.8281.426.938.963.00--0.00160.00-7.77-4.98-8.02-12.764.86--
MacroGenics Inc58.75m-9.06m933.98m339.00--6.081,593.8315.90-0.1525-0.15250.94622.460.2036.151.76173,300.90-3.13-37.76-3.82-45.5386.00---15.42-133.964.46-117.570.00---61.33-0.460692.44---41.13--
National Research Corporation148.58m30.96m939.86m435.0031.3819.4925.496.331.261.266.022.021.18--11.00341,563.2024.4926.2533.8036.7762.3063.2020.8423.95--1,929.640.428655.45-1.974.42-2.580.669521.45-5.29
Q32 Bio Inc1.16m-112.96m940.02m7.00--0.7141--813.17-35.16-35.160.359822.640.0074----165,142.90-55.64-34.98-62.45-37.92-----7,532.87-971.76----0.00---63.97-26.32-2,156.96---60.90--
ARS Pharmaceuticals Inc30.00k-54.37m961.16m24.00--4.16--32,038.52-0.5719-0.57190.00032.390.0001----1,250.00-21.13-20.37-21.45-21.32-----181,216.70-17,491.75----0.00---97.72---56.75---17.18--
Innoviva Inc310.46m179.72m966.75m112.006.821.434.493.112.242.243.9610.660.25090.88254.192,771,991.0014.5226.2415.6228.5386.27--57.8976.847.96--0.398---6.303.53-15.99-14.57----
Data as of Mar 28 2024. Currency figures normalised to USANA Health Sciences Inc's reporting currency: US Dollar USD

Institutional shareholders

38.00%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20231.69m8.80%
The Vanguard Group, Inc.as of 31 Dec 20231.55m8.05%
Renaissance Technologies LLCas of 31 Dec 20231.20m6.23%
Pzena Investment Management LLCas of 31 Dec 2023761.62k3.96%
Dimensional Fund Advisors LPas of 31 Dec 2023677.66k3.52%
SSgA Funds Management, Inc.as of 31 Dec 2023437.71k2.28%
Pacer Advisors, Inc.as of 31 Dec 2023337.37k1.75%
Geode Capital Management LLCas of 31 Dec 2023256.23k1.33%
Charles Schwab Investment Management, Inc.as of 31 Dec 2023222.42k1.16%
Morgan Stanley & Co. LLCas of 31 Dec 2023178.19k0.93%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.